Clinical Trial Update: Effect of CAFfeine on Cognition in Alzheimer's Disease [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial investigating CAFfeine for cognitive outcomes in Alzheimer's disease is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease

Drugs mentioned

• Caffeine (caffeine)

Snippet

Sponsor: University Hospital, Lille | Conditions: Alzheimer Disease | Phase 3 | Status: RECRUITING